Page 153 - ACCB 2020
P. 153

Anticuerpos anti nucleares en enfermedades reumáticas. Rosales  & Sosa




                   6.  Mahler M., Meroni P.,Bssuyt X., Fritzler M. (2014) Current conceps and future directions for the
                       assessment of autobodies to cellular antigens refrred to as Anti- Nuclear antibodies. J Immunol Res:
                       315179.
                   7.  Eissfeller P., Sticherling M., Scholz D., Hennig K., Luttich T, Motz M. (2014). Comparison of different
                       test systems for simultaneus autoantibody detection in connective tissue diseases. Ann N Y Acad Sci;
                       1050(1), 327-339..
                   8.  Álvarez-Razo S., Vallejo-Rosero K.(2017) Prevalencia de enfermedades sistémicas en pacientes some-
                       tidos a extracciones simples. Dom. Cien; 3(3), 470-486.
                   9.  Jeong S., Hwang H., Roh J., Eun Shim J., Kim J., Geun Tae K., Hee Sang T., Hyon Suk K. (2018) Eva-
                       luation of an Automated Screening Assay, Compared to Indirect Immunofl uorescence, an Extractable
                       Nuclear Antigen Assay, and a Line Immunoassay in a Large Cohort of Asian Patients with Antinu-
                       clear Antibody Associated Rheumatoid Diseases: A Multicenter Retrospective Study. J Immunol Res;
                       2018:9094217.
                   10.  Hansson H., Ronnelid J. (2010) Detection of antinuclear antibodies by the Inno-Lia ANA update test
                       in canine systemic rheumatic disease. Vet Clin Pathol; 39(2): 215–220. https://doi.org/10.1111/j.1939-
                       165X.2009.00193.x
                   11.  Benítez P., Rincon L., Quintero JC., Aristizábal H. (2011) Concordance between antinuclear antibody de-
                       termination by inmunofl uorescence and line inmunoassay. Medicina & Laboratorio;17(09-10):429-443.
                   12.  Mendez T., Ochoa L., Posso I., Ortiz E., Naranjo J., Tobón G. (2018) Interpretación de los autoan-
                       ticuerpos  en  enfermedades  reumatológicas.  Rev  Colomb  Reumatol;  25  (2):  112-125.  http://dx.doi.
                       org/10.1016/j.rcreu.2018.02.004.
                   13.  Jiménez  J., Águila  F., Santiago  C., Ramos JL., Vargas JA., Navarrete N., Zamora M., Sabio JM.,
                       Jáimez L. (2014) Diagnóstico diferencial del lupus eritematoso sistémico: Aspectos claves del día a
                       día. Actual Med; 99(792), 104-106.
                   14.  Pérez C., Losans R., Viraldell M. (2017) Enfermedades Autoinmunes Sistémicas: Forma de presenta-
                       ción, evolución y supervivencia en pacientes con Esclerosis Sistémica en pacientes con Síndrome de
                       Sjögren. Tesis doctoral. Pp. 138-145
                   15.  Kokuina E., Chico A., Estévez M., Argüelles A., Casas N., Pérez D., Infante A., Velbes P., Pérez R.
                       (2016) Autoanticuerpos diagnósticos en enfermedades autoinmunes sistémicas y específi cas de órgano
                       Rev cubana med. 45(2)
                   16.  Raman S., Raman A., Amit., Pradhan., Prasant., Dash, Kanaklata., Senapati., Urmila. (2017) Correla-
                       tion of Indirect Immunofl uorescence & Line Immunoassay Method in Detection of Autoimmune Di-
                       seases: an Observational Study at a Tertiary Care Teaching Hospital. Sch J App Med Sci; 5(7A):2520-
                       2526.
                   17.  Walker R., Kumar Y., Saikia B., Anand S., Varma S.,  Singh S. (2016) Use of panel testing for detec-
                       tion of antinuclear antibody in a resource-limited setting: an apprais. Postgrad Med, 128(8), 869–874.
                       https://doi.org/10.1080/00325481.2016.1220808
                   18.  Begum J., Shailaja V., Ümit Türsen MD. (2018) Detection of Sensitivity and Specifi city of Line Immu-
                       no Assay in Comparison with Indirect Immunofl uorescence Assay for the Detection of Anti-Nuclear
                       Antibodies in Diagnosis of Systemic Autoimmune Disorders. Int J Curr Microbiol App Sci; 7(11):
                       743-748
                   19.  Garg S., Srivastava A., Santosh P. (2017) Correlation of Line Immuno Assay with Indirect Immu-
                       nofl uoresence Assay for the Detection of Anti-Nuclear Antibodies in Various Autoimmune Disorders
                       Autoimmune Disorders. Autoimmune Disorders. J Autoimmune Disord; 3(3): 37
                   20.  Oliva JE., Arroyo JL., Oliva J., García MA. (2019) Patrones de tinción de anticuerpos antinucleares
                       identifi cados por Inmunofl uorescencia indirecta en pacientes con enfermedad del tejido conectivo. Rev
                       Med Hered ; 30:33-39. DOI: https://doi.org/10.20453/rmh.v30i1.3470
                   21.  Kavanaugh A., Tomar R., Reveille J., Solomon DH., Hamburger HA. (2000) Guidelines for clinical
                       use of the antinuclear antibody test and testsfor specifi c autoantibodies to nuclear antigens. Arch Pathol
                       Lab Med; 124:71-81.







                                                                                                            153
            Rev. Asoc. Col. Cienc.(Col.), 2020; 32: 143-153
   148   149   150   151   152   153   154   155   156   157   158